Pedo-anemopyretic cold in children with stagnant syndrome
Conditions
Interventions
Control group:Xiao'er Chiqiao Qingre Granules (Sucrose Free)
Experimental group:Xiao'er Chiqiao Qingre syrup
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
1 Years to 13 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of Xiaoer Chiqiao Qingre syrup; 2. Meet the diagnostic criteria for common cold and have at least 1 nasal symptom and 1 pharyngeal symptom sign each with a score of =2; 3. Select children aged 1 to 13 years (<14 years); 4. Temperature =37.5°C within 24 hours prior to the consultation and duration of febrile illness =36 hours; 5.The informed consent process should be in accordance with the regulations, the legal guardian or with the subject child (=8 years old) to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Children with herpes pharyngitis, pharyngeal conjunctival fever, suppurative tonsillitis, lower respiratory tract infections or respiratory tract infections; 2. Children with a history of epilepsy or febrile convulsions, or recurrent respiratory infections; 3. A white blood cell count, absolute neutrophil count, and CRP, all exceeding 1.2 ULN and considered by the investigator to be bacterial infections 4. Children with severe malnutrition, rickets, or other cardiovascular, cerebral, hepatic, renal, and hematopoietic diseases, or psychiatric illnesses 5. Those with a history of allergic rhinitis, which has an impact on the evaluation of nasal symptoms; 6. Children who are allergic to known components of the test drug; 7. Children who have participated in other clinical trials in the 3 months prior to the trial 8. Other pathologies or conditions that, in the judgment of the investigator, have the effect of reducing the likelihood of enrollment or complicating enrollment, such as unstable living environments, transportation difficulties, and other conditions that could lead to loss of visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Single symptom efficacy;Complication rate;Disease efficacy rate;Chinese medicine evidence of healing rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of clinical adverse events/reactions; | — |
Countries
China
Contacts
Public ContactXinmin Li/Siyuan Hu
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed